Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CD44: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
CD44 is a gene implicated in neurodegeneration research. Key relationships include: therapeutic target, activates, inhibits. Associated with Aging, Als, Alzheimer. Connected to 358 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | CD44 |
| Full Name | Cell Surface Glycoprotein |
| Aliases | Page for CD44 |
| Chromosome | 11p13 |
| Protein Type | Receptor |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Molecular Weight | 95 kDa |
| Amino Acids | 341 aa |
| Exons | 19 |
| Pathways | NF-κB, TGF-β |
| NCBI Gene ID | 2115452 |
| Ensembl ID | ENSG00000026508 |
| GeneCards | CD44 |
| Human Protein Atlas | CD44 |
| Associated Diseases | Aging, Als, Alzheimer, Cardiac, dementia |
| Interactions | ADAM10, AKT, ALS, ALZHEIMER, ALZHEIMER DISEASE, ALZHEIMER'S DISEASE |
| KG Connections | 749 knowledge graph edges |
| Databases | GeneCardsUniProtHPASTRING |
Knowledge base pages for this entity
graph TD
CD44["CD44"]
CD44 -->|"inhibits"| Cancer["Cancer"]
CD44 -->|"inhibits"| Tumor["Tumor"]
CD44 -->|"target for"| Fibrosis["Fibrosis"]
CD44 -->|"target for"| Hepatitis["Hepatitis"]
CD44 -->|"target for"| Carcinoma["Carcinoma"]
CD44 -->|"target for"| Als["Als"]
CD44 -->|"target for"| Inflammation["Inflammation"]
FGF20["FGF20"] -->|"target for"| CD44
BRG1["BRG1"] -->|"target for"| CD44
NRCAM["NRCAM"] -->|"target for"| CD44
NOTCH2["NOTCH2"] -->|"target for"| CD44
EP300["EP300"] -->|"target for"| CD44
CTNNB1["CTNNB1"] -->|"target for"| CD44
NEUROD1["NEUROD1"] -->|"target for"| CD44
MYC["MYC"] -->|"target for"| CD44| Target | Relation | Type | Str |
|---|---|---|---|
| CANCER | therapeutic_target | gene | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| Tumor | therapeutic_target | disease | 0.95 |
| ERK | activates | protein | 0.88 |
| Als | therapeutic_target | disease | 0.85 |
| MICROGLIA | upregulates | cell_type | 0.85 |
| Tumor | inhibits | disease | 0.85 |
| microglia | upregulates | cell_type | 0.80 |
| microglia migration | promotes | process | 0.80 |
| Lung Cancer | therapeutic_target | disease | 0.75 |
| Cancer | inhibits | disease | 0.75 |
| Inflammation | therapeutic_target | disease | 0.75 |
| Cancer | activates | disease | 0.75 |
| Fibrosis | therapeutic_target | disease | 0.75 |
| Als | associated_with | disease | 0.75 |
| Als | activates | disease | 0.75 |
| Carcinoma | activates | disease | 0.75 |
| Pancreatic Cancer | therapeutic_target | disease | 0.75 |
| Mapk | inhibits | pathway | 0.70 |
| Notch | therapeutic_target | pathway | 0.70 |
| HIF | therapeutic_target | gene | 0.70 |
| CANCER | inhibits | gene | 0.70 |
| ABCB1 | therapeutic_target | gene | 0.70 |
| SOX2 | inhibits | gene | 0.70 |
| lipid metabolism | participates_in | pathway | 0.70 |
| Glycolysis | therapeutic_target | pathway | 0.70 |
| CANCER | activates | gene | 0.70 |
| MYC | targets | gene | 0.70 |
| Rheumatoid Arthritis | therapeutic_target | disease | 0.65 |
| Breast Cancer | therapeutic_target | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| Neuroinflammation | interacts_with | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Hepatocellular Carcinoma | therapeutic_target | disease | 0.65 |
| Stroke | interacts_with | disease | 0.65 |
| Pulmonary Fibrosis | therapeutic_target | disease | 0.65 |
| ALS | interacts_with | disease | 0.65 |
| Stroke | expressed_in | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Infection | activates | disease | 0.65 |
| Senescence | activates | disease | 0.65 |
| Neuroinflammation | protects_against | disease | 0.65 |
| Huntington | associated_with | disease | 0.65 |
| Liver Cancer | therapeutic_target | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Neuroinflammation | associated_with | disease | 0.65 |
| Fibrosis | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| SPP1 | binds_to | protein | 0.93 |
| AKT | regulates | protein | 0.85 |
| MYC | enhances | gene | 0.70 |
| INFLAMMATION | therapeutic_target | gene | 0.70 |
| ASTROCYTES | associated_with | gene | 0.60 |
| ASTROCYTE | associated_with | gene | 0.60 |
| COMPLEMENT | contributes_to | gene | 0.60 |
| FN1 | associated_with | gene | 0.60 |
| JAK | activates | gene | 0.60 |
| HUNTINGTON'S DISEASE | associated_with | gene | 0.60 |
| ASTROCYTE | interacts_with | gene | 0.60 |
| PARKINSON | associated_with | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| COMPLEMENT | interacts_with | gene | 0.60 |
| COMPLEMENT | regulates | gene | 0.60 |
| APOPTOSIS | regulates | gene | 0.60 |
| INFLAMMATION | regulates | gene | 0.60 |
| DACH1 | inhibits | gene | 0.60 |
| RNA | inhibits | gene | 0.60 |
| STROKE | interacts_with | gene | 0.60 |
| RNA | associated_with | gene | 0.60 |
| ALZHEIMER | interacts_with | gene | 0.60 |
| ASTROCYTES | interacts_with | gene | 0.60 |
| RUNX2 | associated_with | gene | 0.60 |
| CCL2 | associated_with | gene | 0.60 |
| ALZHEIMER | expressed_in | gene | 0.60 |
| DEMENTIA | expressed_in | gene | 0.60 |
| HUNTINGTON | associated_with | gene | 0.60 |
| NEUROINFLAMMATION | interacts_with | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| GENES | regulates | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| AGING | associated_with | gene | 0.60 |
| CD24 | inhibits | gene | 0.60 |
| RNA | therapeutic_target | gene | 0.60 |
| STROKE | associated_with | gene | 0.60 |
| CCND1 | targets | gene | 0.60 |
| ALDH1A1 | targets | gene | 0.60 |
| CLDN1 | therapeutic_target | gene | 0.60 |
| AXIN1 | therapeutic_target | gene | 0.60 |
| ANXA2 | activates | gene | 0.60 |
| ICAM1 | activates | gene | 0.60 |
| CDKN2A | inhibits | gene | 0.60 |
| TLR4 | inhibits | gene | 0.60 |
| TNC | inhibits | gene | 0.60 |
| NTRK2 | inhibits | gene | 0.60 |
| PAK1 | inhibits | gene | 0.60 |
| WNT7A | inhibits | gene | 0.60 |
| LZTS1 | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Hypothesis 2: GPNMB-CD44 Axis as Anti-inflammatory Pathway | 0.772 | neurodegeneration | View |
| CD44-Mediated Src/PI3K/Akt Signaling Cascade | 0.470 | neuroinflammation | What molecular mechanisms mediate SPP1-i |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| The temporal and stimuli-specific effects of LPS and IFNγ on microglial activati [PMID:41695273] | Heiss CN, Naylor AS, Pesämaa I, Meshi A, | Front Aging Neurosci | 2026 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning CD44 in their description or question text
No additional research found